Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
Conditions
Recurrent Ovarian High Grade Serous Adenocarcinoma · Recurrent Platinum-Resistant Ovarian Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States
Contact: Principal Investigator (Sami Dwabe)Los Angeles General Medical Center, Los Angeles, California, United States
Contact: Principal Investigator (Anastasia Martynova)USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Contact: Principal Investigator (Anastasia Martynova)UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
Contact: Principal Investigator (Sami Dwabe)UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States
Mayo Clinic in Florida, Jacksonville, Florida, United States
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States
Northwestern University, Chicago, Illinois, United States
University of Kansas Clinical Research Center, Fairway, Kansas, United States
Contact: Principal Investigator (Andrea D. Jewell)University of Kansas Cancer Center, Kansas City, Kansas, United States
University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States
University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas, United States
University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Contact: Principal Investigator (Andrea E. Wahner Hendrickson)University of Kansas Cancer Center - North, Kansas City, Missouri, United States
University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States
University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri, United States
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (Janelle Darby)Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (John L. Hays)University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Lauren E. Dockery)Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Mitchell I. Edelson)Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Alaina J. Brown)University of Virginia Cancer Center, Charlottesville, Virginia, United States
Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303Contact: Principal Investigator (Linda R. Duska)
Study leads
Camille Jackson
Principal Investigator
Yale University Cancer Center LAO